Nicotine Lozenge
Product Images NDC 59779-734

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Nicotine (NDC 59779-734). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cvs Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

734 17 Nicotine Lozenge

This text contains information about a Nicotine Polacrilex Lozenge 2 mg (nicotine) Stop Smoking Aid, manufactured and distributed by CVS Health. It features details about the product such as directions, drug facts, and the use of the lozenge in preventing the withdrawal symptoms associated with smoking cessation. The package also contains warnings about possible side effects and precautions that must be taken while using the product. The package has a tamper-resistant seal that is visible, and information about the coupon discount that comes with it.*

FDA Label Image

Wallet Card Image 1 (Image 01)

FDA Label Image

Wallet Card Image 2 (Image 02)

The text provides information on a wallet card that contains contact numbers for organizations that offer help to individuals seeking assistance with lung diseases, cancer or heart-related issues. These organizations include the American Lung Association, the American Cancer Society, and the American Heart Association. The card also suggests having a "Quitting Buddy" or a friend who has already quit smoking to help with quitting.*

FDA Label Image

Smoke Free Habits Logo (Image 03)

IS_I okeFree is a website for Free & Personalized Support Plan related to some topic.*

FDA Label Image

Upc Example (Image 04)

FDA Label Image

Reminder Stickers (Image 05)

The text appears to be a set of reminders to be placed on a calendar for smoking cessation. It includes instructions for the use of lozenges during the first and third weeks after quitting, with varying frequency depending on the week. A reminder is also given for the 12th week after the quit date.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.